246 related articles for article (PubMed ID: 33252592)
1. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
2. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of bone turnover markers and thyroid indicators for bone metabolism in GD patients after treatment.
Su M; Chai J; Zheng W; Jia Q; Tan J; He Y; Zhang R; Men J; Liu W; Shi T; Ren J; Dong L; Liu L; Meng Z
Front Endocrinol (Lausanne); 2024; 15():1301213. PubMed ID: 38742199
[TBL] [Abstract][Full Text] [Related]
7. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism.
Giovanella L; Ceriani L; Ghelfo A
Horm Metab Res; 2008 Jul; 40(7):484-6. PubMed ID: 18393171
[TBL] [Abstract][Full Text] [Related]
8. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
9. Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
Harvengt J; Boizeau P; Chevenne D; Zenaty D; Paulsen A; Simon D; Guilmin Crepon S; Alberti C; Carel JC; Léger J
Eur J Endocrinol; 2015 Jun; 172(6):715-23. PubMed ID: 25766047
[TBL] [Abstract][Full Text] [Related]
10. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
11. Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease.
Nagasaki T; Inaba M; Fujiwara-Ueda M; Nishio J; Kumeda Y; Hiura Y; Tahara H; Ishimura E; Ishiko O; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):113-7. PubMed ID: 20006462
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-21 is associated with disease activity in patients with Graves' disease.
Zhang J; Zeng H; Ren M; Yan H; Xu M; Feng Z; Liang W; Yang C; Cheng H; Ding H; Yan L
Endocrine; 2014 Aug; 46(3):539-48. PubMed ID: 24287789
[TBL] [Abstract][Full Text] [Related]
14. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
Sawicka N; Sowiński J
Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
16. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
17. Conversion to Graves disease from Hashimoto thyroiditis: a study of 24 patients.
Gonzalez-Aguilera B; Betea D; Lutteri L; Cavalier E; Geenen V; Beckers A; Valdes-Socin H
Arch Endocrinol Metab; 2018; 62(6):609-614. PubMed ID: 30624501
[TBL] [Abstract][Full Text] [Related]
18. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
19. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
20. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease.
Suzuki N; Inoue K; Yoshimura R; Kinoshita A; Suzuki A; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Noh JY; Katoh R; Sugino K; Ito K
Thyroid; 2022 Oct; 32(10):1243-1248. PubMed ID: 36074931
[No Abstract] [Full Text] [Related]
[Next] [New Search]
